Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?
Tidsskr Nor Laegeforen. 2020 May 14;140(9).
doi: 10.4045/tidsskr.20.0411.
Print 2020 Jun 16.
[Article in
English,
Norwegian]
No abstract available
MeSH terms
-
Angiotensin Receptor Antagonists* / adverse effects
-
Angiotensin-Converting Enzyme Inhibitors / adverse effects
-
Betacoronavirus
-
COVID-19
-
Coronavirus Infections* / complications
-
Humans
-
Pandemics*
-
Pneumonia, Viral* / complications
-
SARS-CoV-2
-
Severity of Illness Index
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors